German Tech Holding’s Rights‑Issue: A High‑Risk Pivot to Life Sciences & What It Means for Shareholders
German Tech Holding’s new rights‑issue bets on Zirnostics’ unverified PSMA tracer—could this risky pivot to life sciences dilute shareholders or spark a breakthrough?
4 minutes to read